Mediqventures is a biotech merchant bank and investment firm. It invests in companies with late-stage preclinical or early-stage clinical therapeutic assets with particular attention to metabolic disease, oncology and infectious disease. The firm provides equity financing either directly to portfolio companies or to single-asset collaborations with existing companies. The firm was founded in 2011 and is based in Douglas, United Kingdom.